Development of a multi-targeted metabolomics platform for semi-quantification of faecal metabolites: a proof-of-concept analysis in human faeces
- Microbiome Res Rep. 2026 Mar 26;5(1):7. doi: 10.20517/mrr.2025.85.
- 1. These authors contributed equally to this work.
- 2. Shimadzu Corporation, Kyoto 604-8511, Japan.
- 3. The University of Osaka and Shimadzu Analytical Innovation Research Laboratories, The University of Osaka, Osaka 565-0871, Japan.
- 4. Department of Biotechnology, Graduate School of Engineering, The University of Osaka, Osaka 565-0871, Japan.
- 5. Dairy Science and Technology Institute, Kyodo Milk Industry Co. Ltd, Tokyo 190-0182, Japan.
- 6. BC LAB, Osaka 541-0047, Japan.
- 7. Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.
- 8. Leicester NIHR Biomedical Research Centre and BHF Centre of Research Excellence, University of Leicester, Leicester LE1 7RH, UK.
- 9. The Institute of Medical Science, The University of Tokyo, Tokyo 108-0071, Japan.
Objectives: Targeted metabolomic analysis of faecal samples has been limited by narrow chemical coverage. Here, we established a multiplexed, triple quadrupole mass spectrometry (TQMS)-based targeted metabolomics workflow. This workflow allows accurate detection and semi-quantification of diverse faecal metabolites and provides a methodological platform for studying host-microbiome metabolic interactions. Methods: Faecal metabolomes from germ-free (GF) mice, ex-germ-free (Ex-GF) mice, and human participants were analysed using TQMS-based targeted metabolomics. The analysis comprised multiple methods targeting Amino acids and their derivatives, Carbohydrates, short-chain Fatty Acids, Bile Acids, lipid mediators, and Phospholipids. Results: In total, 607 low-molecular-weight metabolites in 44 chemical categories were detected and semi-quantified. Faecal metabolomes of GF and Ex-GF mice were analysed, uncovering 341 intestinal microbiome-dependent metabolites. A proof-of-concept analysis using faecal samples from five patients with Colorectal Cancer demonstrated the successful application of this platform to human clinical material, highlighting its strong potential for future disease-oriented metabolomic investigations. Conclusion: We developed a multi-targeted faecal metabolomics platform that substantially expands the chemical space accessible to targeted analysis. This workflow provides a methodological foundation for future large-scale and translational studies.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Metabolic Disease